StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
80
This month
1
This year
6
Publishing Date
2023 - 02 - 23
1
2023 - 01 - 09
1
2022 - 11 - 22
1
2022 - 11 - 17
1
2022 - 11 - 04
1
2022 - 11 - 01
1
2022 - 10 - 20
1
2022 - 10 - 17
1
2022 - 10 - 10
1
2022 - 09 - 21
1
2022 - 09 - 19
1
2022 - 09 - 15
1
2022 - 09 - 13
1
2022 - 09 - 12
1
2022 - 09 - 08
1
2022 - 07 - 27
1
2022 - 06 - 21
1
2022 - 06 - 07
1
2022 - 06 - 03
1
2022 - 04 - 21
1
2022 - 03 - 28
1
2022 - 03 - 21
1
2022 - 03 - 08
1
2022 - 02 - 05
1
2022 - 02 - 04
1
2022 - 01 - 18
1
2022 - 01 - 14
1
2022 - 01 - 07
1
2022 - 01 - 04
2
2021 - 12 - 31
2
2021 - 12 - 29
1
2021 - 12 - 25
1
2021 - 12 - 17
1
2021 - 12 - 15
2
2021 - 12 - 05
1
2021 - 11 - 26
1
2021 - 11 - 20
1
2021 - 11 - 19
1
2021 - 11 - 10
1
2021 - 10 - 18
2
2021 - 10 - 11
1
2021 - 09 - 16
1
2021 - 09 - 10
1
2021 - 09 - 01
1
2021 - 08 - 27
1
2021 - 08 - 25
1
2021 - 07 - 08
1
2021 - 06 - 29
1
2021 - 05 - 26
1
2021 - 05 - 03
2
2021 - 04 - 27
1
2021 - 04 - 23
1
2021 - 02 - 22
1
2021 - 02 - 12
1
2021 - 01 - 25
1
2021 - 01 - 22
1
2021 - 01 - 07
1
2020 - 12 - 22
1
2020 - 12 - 21
1
2020 - 12 - 17
1
Sector
Commercial services
1
Educational services
1
Finance
4
Health services
1
Health technology
80
Information
4
Professional, scientific, and technical services
2
Technology services
1
Tags
100
1
Aesthetic
3
Application
2
Approval
2
Approved
1
Association
1
Biopharma
1
Biotech
1
Biotech-bay
1
Biotechnology
4
Cell
1
Ces
2
China
1
Clinical-trials-phase-ii
2
Clinical-trials-phase-iii
1
Commercial
1
Conference
6
Daxxify
4
Day
1
Deadline
9
Dermatitis
1
Earnings
8
Enroll
1
Ev
5
Events
17
Fda
6
Fda-approvals
3
Financial
7
Financial results
3
Global
3
Grant
1
Granted
1
Group
1
Growth
1
Health
1
Injection
19
International
2
Iot
1
Ipo
1
Label
1
License
2
Lsd
2
Market
7
Meeting
3
Money
3
N/a
27
Offering
2
People
4
Pharma
3
Phase 3
2
Product-news
2
Report
4
Research
7
Resubmission
2
Results
12
Therapeutics
12
Treatment
5
Trial
2
Xin
2
Year
3
Entities
Abbvie inc.
2
Agenus inc.
1
Akumin inc.
1
Apollo endosurgery, inc.
1
Bausch health companies inc.
1
Cloopen group holding ltd - adr
2
Cohbar, inc.
1
Evolus, inc.
4
Igm biosciences, inc.
1
Johnson & johnson
1
Lightspeed pos inc.
1
Marathon patent group, inc.
1
Mimedx group, inc
1
Organogenesis holdings inc.
4
Owlet inc - class a
1
Playtika holding corp
2
Revance therapeutics, inc.
80
Sanofi
1
Sarepta therapeutics, inc.
2
Seer inc - class a
2
Sientra, inc.
1
Stoneco ltd.
1
Tuya inc - adr
2
Viatris inc.
25
Zhangmen education inc - adr
1
Symbols
AAPL
1198
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1797
ACN
602
AMGN
744
ARVL
4321
AVGO
597
AZN
668
BDX
796
BMY
662
BNPQF
1769
BNPQY
1769
CSCO
900
DHR
786
ERIC
1617
F
643
FNCTF
7230
FRBA
602
GE
919
GLAXF
661
GOOG
1297
GOOGL
1296
GSK
887
HON
1793
HUBS
1400
IBM
657
INTC
956
IT
595
JNJ
4608
LLY
1712
LTUM
973
LYV
717
MDT
1286
MMM
938
MS
4299
MSFT
1205
MT
593
NOK
917
NOKBF
993
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1132
PPRUY
1133
SAP
1481
SAPGF
1235
SNOW
796
SNY
4563
SNYNF
3621
TEVJF
633
TMO
1630
VZ
1223
XYF
678
Exchanges
Nasdaq
80
Nyse
7
Crawled Date
2023 - 03 - 01
1
2023 - 02 - 27
1
2023 - 02 - 23
1
2023 - 01 - 09
1
2022 - 11 - 22
1
2022 - 11 - 17
1
2022 - 11 - 04
1
2022 - 11 - 01
1
2022 - 10 - 20
1
2022 - 10 - 17
1
2022 - 10 - 10
1
2022 - 09 - 21
1
2022 - 09 - 19
1
2022 - 09 - 15
1
2022 - 09 - 13
1
2022 - 09 - 12
1
2022 - 09 - 08
1
2022 - 07 - 27
1
2022 - 06 - 21
1
2022 - 06 - 07
1
2022 - 06 - 03
1
2022 - 04 - 22
1
2022 - 03 - 28
1
2022 - 03 - 21
1
2022 - 03 - 08
1
2022 - 02 - 05
2
2022 - 01 - 19
1
2022 - 01 - 14
1
2022 - 01 - 07
1
2022 - 01 - 04
2
2021 - 12 - 31
2
2021 - 12 - 29
1
2021 - 12 - 26
1
2021 - 12 - 17
1
2021 - 12 - 15
2
2021 - 12 - 05
1
2021 - 11 - 26
1
2021 - 11 - 20
1
2021 - 11 - 19
1
2021 - 11 - 10
1
2021 - 10 - 18
2
2021 - 10 - 11
1
2021 - 09 - 16
1
2021 - 09 - 10
1
2021 - 09 - 01
1
2021 - 08 - 27
1
2021 - 08 - 25
1
2021 - 07 - 08
1
2021 - 06 - 29
1
2021 - 05 - 26
1
2021 - 05 - 03
2
2021 - 04 - 27
1
2021 - 04 - 23
1
2021 - 02 - 22
1
2021 - 02 - 12
1
2021 - 01 - 25
1
2021 - 01 - 22
1
2021 - 01 - 07
1
2020 - 12 - 22
2
2020 - 12 - 17
1
Crawled Time
00:00
1
00:20
2
01:00
3
04:00
1
04:20
1
05:00
5
06:00
1
10:00
1
11:00
1
12:00
3
12:15
1
12:20
1
13:00
15
13:15
3
13:20
2
14:00
12
14:20
1
15:00
5
15:20
1
15:30
1
16:00
2
16:20
2
17:00
1
18:00
3
19:00
6
20:00
1
21:00
2
22:00
1
23:00
1
Source
www.biospace.com
53
www.globenewswire.com
1
www.prnewswire.com
26
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
RVNC
save search
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published:
2024-04-12
(Crawled : 13:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-0.17%
|
O:
-0.17%
H:
0.17%
C:
-1.9%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-20.31%
|
O:
-2.01%
H:
1.37%
C:
-5.92%
daxxify
neurology
meeting
Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
Published:
2024-03-04
(Crawled : 17:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-8.26%
|
O:
0.0%
H:
0.08%
C:
-1.83%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-48.85%
|
O:
-11.6%
H:
3.89%
C:
-1.62%
million
offering
Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024
Published:
2024-02-21
(Crawled : 15:30)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-12.76%
|
O:
-0.15%
H:
0.76%
C:
0.3%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-35.21%
|
O:
0.18%
H:
0.72%
C:
-2.72%
year
financial
results
Global Cell Penetrating Peptide Market Forecast Report to 2030, Featuring Biosynth, Creative Peptides, Cupid Peptide, Alta Bioscience, AnaSpec, Peptomyc, PolyPeptide, Bachem & Sarepta Therapeutics
Published:
2024-02-05
(Crawled : 11:00)
- prnewswire.com
SRPT
|
$124.27
6.11%
5.75%
1.3M
|
Health Technology
|
2.46%
|
O:
0.12%
H:
3.45%
C:
3.4%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-33.52%
|
O:
-2.42%
H:
1.05%
C:
-2.67%
report
cell
global
therapeutics
market
Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference
Published:
2024-02-01
(Crawled : 21:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-1.87%
|
O:
-0.42%
H:
1.75%
C:
1.28%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-29.03%
|
O:
1.59%
H:
4.11%
C:
0.78%
conference
Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook
Published:
2024-01-08
(Crawled : 14:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-3.59%
|
O:
-0.83%
H:
0.72%
C:
-1.43%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-57.25%
|
O:
-13.17%
H:
3.45%
C:
-2.76%
year
financial
Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
Published:
2023-11-01
(Crawled : 13:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
29.78%
|
O:
-0.45%
H:
0.96%
C:
0.68%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-54.75%
|
O:
-0.63%
H:
1.66%
C:
1.15%
financial
results
Global Facial Injectable Market Analysis Report 2023-2028: New Product Launches, Increased Male Aesthetics, and Emerging Markets Driving Growth
Published:
2023-09-06
(Crawled : 10:00)
- prnewswire.com
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.85%
|
O:
-0.1%
H:
0.0%
C:
0.0%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-79.59%
|
O:
-0.46%
H:
1.38%
C:
-2.87%
EOLS
|
$11.48
-1.88%
-1.92%
260K
|
Health Technology
|
18.19%
|
O:
0.41%
H:
0.92%
C:
-0.1%
report
global
growth
market
Revance to Host Investor Day on September 19, 2023
Published:
2023-08-22
(Crawled : 14:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
2.67%
|
O:
-0.18%
H:
0.45%
C:
-0.62%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-79.66%
|
O:
0.28%
H:
2.33%
C:
1.65%
day
U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
Published:
2023-08-14
(Crawled : 13:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
1.76%
|
O:
-0.35%
H:
0.0%
C:
-1.06%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-81.12%
|
O:
6.13%
H:
1.54%
C:
-3.04%
daxxify
fda
treatment
injection
Revance to Release Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
Published:
2023-08-01
(Crawled : 13:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
9.69%
|
O:
-0.19%
H:
0.29%
C:
-2.76%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-84.89%
|
O:
-1.1%
H:
0.0%
C:
0.0%
financial
results
Revance to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
Published:
2023-05-02
(Crawled : 12:20)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
23.4%
|
O:
-0.21%
H:
0.21%
C:
-2.36%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-88.94%
|
O:
0.65%
H:
2.62%
C:
1.97%
financial
results
Revance to Participate in Upcoming Investor Conferences - March 7, 2023
Published:
2023-03-07
(Crawled : 14:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
6.35%
|
O:
0.09%
H:
0.18%
C:
-1.29%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-89.18%
|
O:
0.36%
H:
0.69%
C:
-0.6%
Facial Injectable Global Market Report 2022: Sector to Reach $23.55 Billion by 2027 at a 15.46% CAGR
Published:
2023-03-01
(Crawled : 04:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-1.42%
|
O:
-1.29%
H:
0.0%
C:
-0.13%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-8.06%
|
O:
0.64%
H:
0.85%
C:
-1.6%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
9.03%
|
O:
-0.74%
H:
1.85%
C:
1.64%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
0.31%
|
O:
-0.11%
H:
0.0%
C:
0.0%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-89.71%
|
O:
-3.46%
H:
3.43%
C:
-3.73%
global
report
market
Revance to Participate in the 43rd Annual Cowen Healthcare Conference
Published:
2023-02-27
(Crawled : 14:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
0.35%
|
O:
-1.13%
H:
3.69%
C:
-1.58%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-89.54%
|
O:
0.79%
H:
3.84%
C:
2.06%
conference
Revance to Present New Data on DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia at the Association of Academic Physiatrists Annual Meeting
Published:
2023-02-23
(Crawled : 15:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
0.52%
|
O:
0.0%
H:
1.61%
C:
0.44%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-89.2%
|
O:
0.48%
H:
4.73%
C:
2.5%
daxxify
treatment
meeting
association
injection
Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results
Published:
2023-01-09
(Crawled : 19:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-4.55%
|
O:
0.17%
H:
0.58%
C:
-0.91%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-81.89%
|
O:
15.12%
H:
34.86%
C:
34.07%
daxxify
commercial
year
financial
update
results
Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference
Published:
2022-11-22
(Crawled : 14:00)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
4.15%
|
O:
-1.35%
H:
1.46%
C:
1.19%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-83.85%
|
O:
-0.14%
H:
3.44%
C:
2.76%
conference
Nanostics Announces New Member of Board of Directors
Published:
2022-11-17
(Crawled : 14:00)
- biospace.com/
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-84.58%
|
O:
-1.81%
H:
0.88%
C:
-3.34%
Revance Announces Two Publications in The Aesthetic Surgery Journal That Advance Glabellar Line Injection Technique and Assessment
Published:
2022-11-04
(Crawled : 13:20)
- biospace.com/
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
19.44%
|
O:
0.83%
H:
1.33%
C:
-0.51%
RVNC
|
$3.57
-2.46%
-2.52%
1.8M
|
Health Technology
|
-83.4%
|
O:
1.44%
H:
0.0%
C:
-2.93%
aesthetic
injection
← Previous
1
2
3
4
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.